UK Life Sciences and Healthcare Newsletter - December 2020: Antimicrobial Resistance (AMR) – A Personal Perspective

Published date02 December 2020
Subject MatterLife Sciences,Emerging Growth Companies,Venture Capital,Investment Opportunities,Antibiotics,UK,Research and Development,Public Health,Infectious Diseases,Antimicrobials,Pharmaceutical Industry,Coronavirus/COVID-19
Law FirmDechert LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT